| 1 | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine. 2022;14:3469 doi: 10.3390/cancers14143469 |
| 2 | How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?. 2022;10:1618 doi: 10.3390/healthcare10091618 |
| 3 | Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. 2021;9:1242 doi: 10.3390/biomedicines9091242 |
| 4 | Integrative, In Silico and Comparative Analysis of Breast Cancer Secretome Highlights Invasive-Ductal-Carcinoma-Grade Progression Biomarkers. 2022;14:3854 doi: 10.3390/cancers14163854 |
| 5 | Liquid Biopsy as a Diagnostic and Prognostic Tool for Women and Female Dogs with Breast Cancer. 2021;13:5233 doi: 10.3390/cancers13205233 |
| 6 | Potential utility of miRNAs for liquid biopsy in breast cancer. 2022;12: doi: 10.3389/fonc.2022.940314 |
Journal of Cancer Metastasis and Treatment
